Ceyda Oksel
(University of Leeds)
3/10/15, 2:40 PM
Parallel session 4B: Toxicology and human health risks
There are increasing number of engineered nanomaterials (ENMs) that have to be hazard
tested before they are allowed to be used in commercial and industrial applications. This requires new methodologies to be explored and implemented to rapidly and effectively screen and evaluate ENM toxicity. Data-driven models of nanostructure-biological activity relationships are becoming...
Maria Joao Silva
(National Institute of Health Doutor Ricardo Jorge)
3/10/15, 3:04 PM
Parallel session 4B: Toxicology and human health risks
Fundamental and application-driven research in nanotechnology is expected to boost nanoscience and innovation towards development of safe-by-design nanomaterials (NM). In this scenario, adding vast societal benefits, a multi-disciplinary approach to responsible innovation must be undertaken. Although the widespread use of NM, it is not clear whether they impact on environment and human health,...
Elijiah Petersen
(NIST)
3/10/15, 3:28 PM
Parallel session 4B: Toxicology and human health risks
Design and development of reliable cell-based nanotoxicology assays are important for evaluation of potentially hazardous engineered nanomaterials. Challenges to producing a reliable assay protocol include working with nanoparticle dispersions and living cell lines, and the potential for nano-related interference effects. We demonstrate the use of a 96-well plate design for a...
Seda Keleştemur
(Yeditepe University)
3/10/15, 3:52 PM
Parallel session 4B: Toxicology and human health risks
The aim of the study is to develop new modification and synthesis strategies to reduce the toxicity of nanoparticles (NPs) used in ink and pigment industry. Zinc oxide (ZnO) NPs, quantum dots (QDs) and silver nanoparticles (AgNPs) were selected NPs due to their high toxicity. Biocompatibility, stability in ink formulation, chemical suitability, cost and applicability are the main requirements...
Susan Wijnhoven
(RIVM)
3/10/15, 4:16 PM
Parallel session 4B: Toxicology and human health risks
One of the main goals of work package 7 of the GUIDEnano project is to develop a risk assessment strategy for an NM-enabled product during its development and before introduction on the market. This risk assessment strategy is incorporated in the interactive web-based GUIDEnano Tool, which will guide the NM-enabled product developers (mainly industry) into the design and application of the...